ZOPTEC: Phase Iii Randomized Controlled Study Comparing Zoptarelin with Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer (Nct01767155).

AuthID
P-00V-TB7
11
Author(s)
Bondarenko, I
·
Westermann, AM
·
Oaknin, A
·
Oza, AM
·
Lisyanskaya, AS
·
Vergote, I
·
Wenham, RM
·
Temkin, SM
·
Gabra, H
Tipo de Documento
Article
Year published
2018
Publicado
in Journal of Clinical Oncology, ISSN: 0732-183X
Volume: 36, Número: 15_suppl, Páginas: 5503-5503
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.